Stress Management in Obesity During a Thermal Spa Residential Program (ObesiStress)
Primary Purpose
Obesity, Stress
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
21-day residential program
Sponsored by

About this trial
This is an interventional prevention trial for Obesity focused on measuring stress, prevention, obesity, spa, psychology, biomarkers
Eligibility Criteria
Inclusion Criteria:
- Overweight or obese participants with Body Mass Index (BMI) >25 kg.m-2
- Spontaneously candidate to the spa program of Vichy for management of obesity
- Aged over 18 years old
- A stable weight during the last three months
- No hepatic, renal or endocrine diseases uncontrolled
- Ability to give a written informed consent -- Affiliated to French health care system (for France)
Exclusion Criteria:
- Participant refusal to participate
- Pregnant and breastfeeding women
Sites / Locations
- CHU Clermont-Ferrand
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
intervention group
usual practice group
Arm Description
stress management program and the same usual practice (restrictive diet, physical activity and thermal spa treatment)
Both groups will benefit of a 21-day residential program at the thermal spa resort combining corrections of eating disorders
Outcomes
Primary Outcome Measures
heart rate variability (biomarker of both stress and morbidity/mortality)
To assess the ability of a short spa residential program of management of work-related stress in increasing heart rate variability, a biomarker of both stress and morbidity/mortality.
Heart rate variability will be measured by zephyr during 26h recording time
Secondary Outcome Measures
skin conductance
skin conductance will be measured using Wirst band electrodes
blood flow velocity
blood flow velocity will be measured using laser speckle contrast imaging
myocardial longitudinal strain
myocardial longitudinal strain will be measured using speckle tracking echocardiography
Genetic polymorphisms related to stress
Genetic polymorphisms related to stress will be measured using blood cells (angiotensin converting enzyme and serotonin)
Demographics information
Demographics information will be obtained using a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events
Anthropometry
Anthropometry parameters will be obtained according to the ISAK recommendations
Body composition
Body composition (muscle and fat) will be measured using Impedancemeter
Body composition
Body composition (muscle and fat) will be measured using dual x-ray absorption
bone microarchitecture
bone microarchitecture will be measured using peripheral quantitative computed tomography
bone mass
bone mass will be measured using dual x-ray absorption
bone mass
bone mass will be measured using quantitative ultrasounds
General Health
General Health will be measured using the General Health Questionnaire, (there is no score, just informative health information)
Physical Activity
Physical Activity will be measured using the Recent Physical Activity Questionnaire (All activities are categorised depending on intensity: sedentary (<1.5 MET); light (1.5 to <3 MET), moderate-to-vigorous (>3MET))Questionnaire
Depression and anxiety
Depression and anxiety will be measured using the Hospital anxiety and depression scale (scale range from 0 to 3, with a total score between 0 to 21. Threshold score is 8
Burn-out
Burn-out will be measured using the Maslach Burn Out Inventory (scale range from 0 to 6, with 0 = never and 6 = almost always)
Job content
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
anxiety
anxiety will be measured using the state and trait anxiety inventory scale (scale range from 1 to 4, with a total score between 20 to 80. If <35 poor level of anxiety, if > 66 very high level of anxiety)
mindfulness
mindfulness will be measured using the Freiburg mindfulness inventory scale (scale range from 1 to 4, with 1 = almost never, 4 = almost always)
self-efficacy
self-efficacy will be measured using the perceived self-efficacy scale (scale range from 1 to 4, with 1= wrong and 4 = true)
Alexithymia
Alexithymia will be measured using the Toronto Alexithymia scale (scale range from 1 to 5, with 1 = not agreed, 5 = totally agreed)
coping responses
coping responses will be measured using the brief COPE questionnaire (scale range from 1 to 4, with 1 = not agreed, 4 = totally agreed)
emotion regulation
emotion regulation will be measured using the emotion regulation questionnaire (scale range from 1 to 7, with 1 = not agreed, 7 = totally agreed)
metacognition
metacognition will be measured using the metacognition questionnaire MQC-30 (scale range from 1 to 4, with 1 = not agreed, 4 = totally agreed)
illness perception
illness perception will be measured using the brief illness perception questionnaire (B-IPQ 9 items, scale range from 0 to 10)
lifestyle behaviours
lifestyle behaviours will be measured using the lifestyle questionnaire
workplace stress
workplace stress will be measured using the Inner Correspondence/Peaceful Harmony with practices - ICPH (17 items, a 5-point scale from disagreement to agreement, scores >50% indicate higher agreement while scores <50 indicate disagreement).
Basic biology
HbA1c (mmol/mol) will be measured using endocrine assays
appetite markers
Leptin (ng/mL) will be measured using endocrine assays
Pro-inflammatory cytokine
IL-1β will be measured using endocrine assays
Telomeres length
Telomeres length will be measured using endocrine assays
stress markers
Cortisol (nmol/l) will be measured using endocrine assays
adrenal function
adrenal function will be measured using endocrine assays (Dehydroepiandrosterone - DHEAS)
neurotrophic factors
neurotrophic factors will be measured using endocrine assays (Brain-Derived Neurotrophic Factor -BDNF)
Full Information
NCT ID
NCT03578757
First Posted
March 26, 2018
Last Updated
November 6, 2018
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Regional Council of Auvergne-Rhône-Alpes, European Regional Development Fund, Spa resort of Vichy, Compagnie de Vichy, 1 et 3 avenue Eisenhower, 03200 Vichy, France, Hospital of Vichy, Boulevard Denière, 03200 Vichy, France, Université d'Auvergne, LaPEC laboratory (EA 4278), Avignon University, Avignon, France, Innovatherm, Center of Auvergne for Obesity and its health-related risks (CALORIS), Auvergne, France
1. Study Identification
Unique Protocol Identification Number
NCT03578757
Brief Title
Stress Management in Obesity During a Thermal Spa Residential Program
Acronym
ObesiStress
Official Title
Stress Management in Obesity During a Thermal Spa Residential Program: a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Unknown status
Study Start Date
February 1, 2019 (Anticipated)
Primary Completion Date
March 1, 2021 (Anticipated)
Study Completion Date
April 1, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Regional Council of Auvergne-Rhône-Alpes, European Regional Development Fund, Spa resort of Vichy, Compagnie de Vichy, 1 et 3 avenue Eisenhower, 03200 Vichy, France, Hospital of Vichy, Boulevard Denière, 03200 Vichy, France, Université d'Auvergne, LaPEC laboratory (EA 4278), Avignon University, Avignon, France, Innovatherm, Center of Auvergne for Obesity and its health-related risks (CALORIS), Auvergne, France
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Stress can lead to obesity via inappropriate eating. In addition, obesity is a major stress factor. Furthermore, stressed people are also those who have the greatest difficulties to lose weight. The relationships between obesity and stress are biological via the action of stress on the major hormones regulating appetite (leptin, ghrelin). International recommendation proposals suggest to implement stress management programs in obesity for a sustainable weight loss. Moreover, stress and obesity are two public health issues. Among the multiple physical and psychological consequences of stress and obesity, increased mortality and cardiovascular morbidity seem the main concern. Many spa resorts are specialized in the treatment of obesity in France but actually no thermal spa proposes a specific program to manage stress in obesity.
The main hypothesis is that a thermal spa residential program (21 days) of stress management in obesity will exhibit its efficacy through objective measures of well-being and cardiovascular morbidity.
Detailed Description
The Obesi-Stress protocol was designed to provide a better understanding of the effect of a spa residential program combined with a stress management program on the improvement of heart rate variability in the treatment of obesity.
In the present protocol, parameters are measured on five occasions (inclusion, at the start of the spa, at the end of the spa, at 6 months and at 12 months).
Statistical analysis will be performed using Stata software (version 13; Stata-Corp, College Station, Tex., USA). All statistical tests will be two-sided and p<0.05 will be considered significant. After testing for normal distribution (Shapiro-Wilk test), data will be treated either by parametric or non-parametric analyses according to statistical assumptions. Inter-groups comparisons will systematically be performed 1) without adjustment and 2) adjusting on factors liable to be biased between groups.
Analysis will be performed using Student t-test or Mann-Whitney tests. Linear regression (with logarithmic transformation if necessary) considering an adjustment on covariates fixed according to univariate results, epidemiological relevance and observance to physical activity will complete the analysis. Comparisons of categorical variables will be performed using Chi-squared or Fischer test. Relations between quantitative outcomes will be analyzed using correlation coefficients (Pearson or Spearman). Fisher's Z transformation and William's T2 statistic will be performed to compare correlations between variables and within a single group of subjects. Longitudinal data will be treated using mixt-model analyses in order to treat fixed effects group, time and group x time interaction taking into account between and within participant variability.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Stress
Keywords
stress, prevention, obesity, spa, psychology, biomarkers
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Masking Description
No masking
Allocation
Randomized
Enrollment
140 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
intervention group
Arm Type
Experimental
Arm Description
stress management program and the same usual practice (restrictive diet, physical activity and thermal spa treatment)
Arm Title
usual practice group
Arm Type
Active Comparator
Arm Description
Both groups will benefit of a 21-day residential program at the thermal spa resort combining corrections of eating disorders
Intervention Type
Behavioral
Intervention Name(s)
21-day residential program
Intervention Description
Both groups will benefit of a 21-day residential program at the thermal spa resort combining corrections of eating disorders (and a negative energy balance of 500 kcal/day), physical activity (2h30 per day, minimum), thermal spa treatment (2h per day, minimum), and health education (1h30 per day, minimum: cooking, nutrition and physical activity classes…). Physical activity will be diverse (endurance, strength, circuit training) and personalized to the target of each participant.
The intervention group will benefit from psychological interventions based on validated approaches of stress (3 x 1h30 per week). Participants will attend psychological sessions by group of less than 10 individuals. Individual meeting with the psychologist will occur at least twice: at the beginning of the residential program and at the end.
After the spa residential program, participants will undergo a one-year at-home follow-up.
Primary Outcome Measure Information:
Title
heart rate variability (biomarker of both stress and morbidity/mortality)
Description
To assess the ability of a short spa residential program of management of work-related stress in increasing heart rate variability, a biomarker of both stress and morbidity/mortality.
Heart rate variability will be measured by zephyr during 26h recording time
Time Frame
HRV changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Secondary Outcome Measure Information:
Title
skin conductance
Description
skin conductance will be measured using Wirst band electrodes
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
blood flow velocity
Description
blood flow velocity will be measured using laser speckle contrast imaging
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
myocardial longitudinal strain
Description
myocardial longitudinal strain will be measured using speckle tracking echocardiography
Time Frame
Changes overtime is being assessed. Outcomes will be measured at the beginning of the spa program (day 0) and at six months
Title
Genetic polymorphisms related to stress
Description
Genetic polymorphisms related to stress will be measured using blood cells (angiotensin converting enzyme and serotonin)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
Demographics information
Description
Demographics information will be obtained using a single questionnaire including questions on age, gender, qualification, personal work status, ethnicity, life and occupational events
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
Anthropometry
Description
Anthropometry parameters will be obtained according to the ISAK recommendations
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
Body composition
Description
Body composition (muscle and fat) will be measured using Impedancemeter
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
Body composition
Description
Body composition (muscle and fat) will be measured using dual x-ray absorption
Time Frame
Changes overtime is being assessed. Outcomes will be measured at the beginning of the spa program (day 0) and at one year
Title
bone microarchitecture
Description
bone microarchitecture will be measured using peripheral quantitative computed tomography
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
bone mass
Description
bone mass will be measured using dual x-ray absorption
Time Frame
Changes overtime is being assessed. Outcomes will be measured at the beginning of the spa program (day 0) and at one year.
Title
bone mass
Description
bone mass will be measured using quantitative ultrasounds
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
General Health
Description
General Health will be measured using the General Health Questionnaire, (there is no score, just informative health information)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
Physical Activity
Description
Physical Activity will be measured using the Recent Physical Activity Questionnaire (All activities are categorised depending on intensity: sedentary (<1.5 MET); light (1.5 to <3 MET), moderate-to-vigorous (>3MET))Questionnaire
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
Depression and anxiety
Description
Depression and anxiety will be measured using the Hospital anxiety and depression scale (scale range from 0 to 3, with a total score between 0 to 21. Threshold score is 8
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
Burn-out
Description
Burn-out will be measured using the Maslach Burn Out Inventory (scale range from 0 to 6, with 0 = never and 6 = almost always)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
Job content
Description
Job content will be measured using the Karasek questionnaire (scale range from 1 to 4, with 1= not agreed and 4 = totally agreed)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
anxiety
Description
anxiety will be measured using the state and trait anxiety inventory scale (scale range from 1 to 4, with a total score between 20 to 80. If <35 poor level of anxiety, if > 66 very high level of anxiety)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
mindfulness
Description
mindfulness will be measured using the Freiburg mindfulness inventory scale (scale range from 1 to 4, with 1 = almost never, 4 = almost always)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
self-efficacy
Description
self-efficacy will be measured using the perceived self-efficacy scale (scale range from 1 to 4, with 1= wrong and 4 = true)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
Alexithymia
Description
Alexithymia will be measured using the Toronto Alexithymia scale (scale range from 1 to 5, with 1 = not agreed, 5 = totally agreed)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
coping responses
Description
coping responses will be measured using the brief COPE questionnaire (scale range from 1 to 4, with 1 = not agreed, 4 = totally agreed)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
emotion regulation
Description
emotion regulation will be measured using the emotion regulation questionnaire (scale range from 1 to 7, with 1 = not agreed, 7 = totally agreed)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
metacognition
Description
metacognition will be measured using the metacognition questionnaire MQC-30 (scale range from 1 to 4, with 1 = not agreed, 4 = totally agreed)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
illness perception
Description
illness perception will be measured using the brief illness perception questionnaire (B-IPQ 9 items, scale range from 0 to 10)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
lifestyle behaviours
Description
lifestyle behaviours will be measured using the lifestyle questionnaire
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
workplace stress
Description
workplace stress will be measured using the Inner Correspondence/Peaceful Harmony with practices - ICPH (17 items, a 5-point scale from disagreement to agreement, scores >50% indicate higher agreement while scores <50 indicate disagreement).
Time Frame
: Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
Basic biology
Description
HbA1c (mmol/mol) will be measured using endocrine assays
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
appetite markers
Description
Leptin (ng/mL) will be measured using endocrine assays
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
Pro-inflammatory cytokine
Description
IL-1β will be measured using endocrine assays
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
Telomeres length
Description
Telomeres length will be measured using endocrine assays
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year
Title
stress markers
Description
Cortisol (nmol/l) will be measured using endocrine assays
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
adrenal function
Description
adrenal function will be measured using endocrine assays (Dehydroepiandrosterone - DHEAS)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
Title
neurotrophic factors
Description
neurotrophic factors will be measured using endocrine assays (Brain-Derived Neurotrophic Factor -BDNF)
Time Frame
Changes overtime is being assessed. Outcomes will be measured at inclusion, at the beginning of the spa program (day 0), day 21, at six months and at one year.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Overweight or obese participants with Body Mass Index (BMI) >25 kg.m-2
Spontaneously candidate to the spa program of Vichy for management of obesity
Aged over 18 years old
A stable weight during the last three months
No hepatic, renal or endocrine diseases uncontrolled
Ability to give a written informed consent -- Affiliated to French health care system (for France)
Exclusion Criteria:
Participant refusal to participate
Pregnant and breastfeeding women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lise LACLAUTRE
Phone
04 73 75 49 63
Email
drci@chu-clermontferrand.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Frederic DUTHEIL
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Clermont-Ferrand
City
Clermont-Ferrand
ZIP/Postal Code
63003
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lise LACLAUTRE
Phone
04 73 75 49 63
Email
drci@chu-clermontferrand.fr
First Name & Middle Initial & Last Name & Degree
Frederic DUTHEIL
12. IPD Sharing Statement
Citations:
PubMed Identifier
31874865
Citation
Dutheil F, Chaplais E, Vilmant A, Courteix D, Duche P, Abergel A, Pfabigan DM, Han S, Mobdillon L, Vallet GT, Mermillod M, Boudet G, Obert P, Izem O, Miolanne-Debouit M, Farigon N, Pereira B, Boirie Y. Stress management in obesity during a thermal spa residential programme (ObesiStress): protocol for a randomised controlled trial study. BMJ Open. 2019 Dec 23;9(12):e027058. doi: 10.1136/bmjopen-2018-027058.
Results Reference
derived
Learn more about this trial
Stress Management in Obesity During a Thermal Spa Residential Program
We'll reach out to this number within 24 hrs